Fund shareholders of Maravai LifeSciences Holdings Inc
ISIN US56600D1072 · United States
- Fund shareholders
- 137
- Of which ETFs
- 24 113 other funds
- Value held
- 70.6M $
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| Strategic Equity Allocation Trust John Hancock Variable Insurance Trust | 7,599 | 21.5K $ | 0.00 % | as of Mar 31, 2026 ↗ |
| Voya VACS Index Series SC Portfolio Voya VARIABLE PORTFOLIOS INC | 7,408 | 21K $ | 0.01 % | as of Mar 31, 2026 ↗ |
| ProShares Ultra Russell2000 ProShares Trust | 6,765 | 24.1K $ | 0.01 % | as of Feb 28, 2026 ↗ |
| ProShares UltraPro Russell2000 ProShares Trust | 6,742 | 24K $ | 0.01 % | as of Feb 28, 2026 ↗ |
| ProShares Ultra Nasdaq Biotechnology ProShares Trust | 6,696 | 23.8K $ | 0.03 % | as of Feb 28, 2026 ↗ |
| iShares Total U.S. Stock Market Index Fund BlackRock Funds | 6,620 | 24.4K $ | 0.00 % | as of Apr 30, 2026 ↗ |
| SA U.S. Small Company Fund SA FUNDS INVESTMENT TRUST | 6,182 | 17.5K $ | 0.01 % | as of Mar 31, 2026 ↗ |
| LVIP Dimensional U.S. Core Equity 2 Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 5,321 | 15.1K $ | 0.00 % | as of Mar 31, 2026 ↗ |
| Small-Cap Equity Portfolio PACIFIC SELECT FUND | 5,038 | 14.3K $ | 0.01 % | as of Mar 31, 2026 ↗ |
| JNL/DFA U.S. Core Equity Fund JNL Series Trust | 4,911 | 13.9K $ | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Russell 2000 High Income ETF ProShares Trust | 4,734 | 16.9K $ | 0.01 % | as of Feb 28, 2026 ↗ |
| Morgan Stanley Pathway Small-Mid Cap Equity ETF MORGAN STANLEY PATHWAY FUNDS | 4,400 | 15.7K $ | 0.00 % | as of Feb 28, 2026 ↗ |
| AZL DFA U.S. Core Equity Fund Allianz Variable Insurance Products Trust | 4,035 | 11.4K $ | 0.00 % | as of Mar 31, 2026 ↗ |
| LVIP Dimensional U.S. Core Equity 1 Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 3,739 | 10.6K $ | 0.00 % | as of Mar 31, 2026 ↗ |
| SmallCap Value Fund II Principal Funds, Inc | 3,569 | 13.1K $ | 0.00 % | as of Apr 30, 2026 ↗ |
| Avantis Total Equity Markets ETF American Century ETF Trust | 3,462 | 12.3K $ | 0.00 % | as of Feb 28, 2026 ↗ |
| TIAA Separate Account VA-1 - Stock Index Account TIAA Separate Account VA-1 | 3,088 | 8.7K $ | 0.00 % | as of Mar 31, 2026 ↗ |
| Harbor AlphaEdge Small Cap Earners ETF Harbor ETF Trust | 3,060 | 11.3K $ | 0.10 % | as of Apr 30, 2026 ↗ |
| EQ/Franklin Small Cap Value Managed Volatility Portfolio EQ Advisors Trust | 3,055 | 8.6K $ | 0.00 % | as of Mar 31, 2026 ↗ |
| State Street Total Return V.I.S. Fund STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 2,969 | 8.4K $ | 0.00 % | as of Mar 31, 2026 ↗ |
| VIP Total Market Index Portfolio Variable Insurance Products Fund II | 2,939 | 8.3K $ | 0.00 % | as of Mar 31, 2026 ↗ |
| Penn Series Small Cap Index Fund Penn Series Funds Inc | 2,900 | 8.2K $ | 0.01 % | as of Mar 31, 2026 ↗ |
| Destinations Small-Mid Cap Equity Fund Brinker Capital Destinations Trust | 2,798 | 10K $ | 0.00 % | as of Feb 28, 2026 ↗ |
| Total Stock Market Index Trust John Hancock Variable Insurance Trust | 2,609 | 7.4K $ | 0.00 % | as of Mar 31, 2026 ↗ |
| Nuveen Life Stock Index Fund TIAA-CREF Life Funds | 1,760 | 5K $ | 0.00 % | as of Mar 31, 2026 ↗ |
| ULTRA SMALL CAP PROFUND ProFunds | 1,235 | 4.5K $ | 0.01 % | as of Apr 30, 2026 ↗ |
| State Street Balanced Index Fund STATE STREET INSTITUTIONAL INVESTMENT TRUST | 950 | 2.7K $ | 0.00 % | as of Mar 31, 2026 ↗ |
| Russell 2000 2x Strategy Fund Rydex Dynamic Funds | 552 | 1.6K $ | 0.00 % | as of Mar 31, 2026 ↗ |
| PROFUND VP ULTRA SMALL CAP ProFunds | 365 | 1K $ | 0.01 % | as of Mar 31, 2026 ↗ |
| PROFUND VP SMALL CAP ProFunds | 276 | 781.1 $ | 0.01 % | as of Mar 31, 2026 ↗ |
| Russell 2000 Fund Rydex Series Funds | 255 | 721.7 $ | 0.01 % | as of Mar 31, 2026 ↗ |
| SMALL-CAP PROFUND ProFunds | 199 | 732.3 $ | 0.01 % | as of Apr 30, 2026 ↗ |
| Columbia Research Enhanced Small Cap ETF Columbia ETF Trust I | 163 | 461.3 $ | 0.02 % | as of Mar 31, 2026 ↗ |
| Russell 2000 1.5x Strategy Fund Rydex Series Funds | 152 | 430.2 $ | 0.01 % | as of Mar 31, 2026 ↗ |
| ProShares Hedge Replication ETF ProShares Trust | 112 | 398.7 $ | 0.00 % | as of Feb 28, 2026 ↗ |
| ProShares Russell 2000 Dynamic Buffer ETF ProShares Trust | 34 | 121 $ | 0.01 % | as of Feb 28, 2026 ↗ |
| Russell 2000(R) 1.5x Strategy Fund Rydex Variable Trust | 29 | 82.1 $ | 0.00 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Lazard Global Small Cap Equity Portfolio LAZARD FUNDS INC | 0.80 % | as of Mar 31, 2026 ↗ |
| Lazard Retirement US Small Cap Equity Select Portfolio LAZARD RETIREMENT SERIES INC | 0.69 % | as of Mar 31, 2026 ↗ |
| Lazard US Small Cap Equity Select Portfolio LAZARD FUNDS INC | 0.68 % | as of Mar 31, 2026 ↗ |
| Invesco NASDAQ Future Gen 200 ETF Invesco Exchange-Traded Fund Trust II | 0.46 % | as of Feb 28, 2026 ↗ |
| Royce Capital Fund - Micro-Cap Portfolio ROYCE CAPITAL FUND | 0.45 % | as of Mar 31, 2026 ↗ |
| Royce Micro-Cap Fund ROYCE FUND | 0.45 % | as of Mar 31, 2026 ↗ |
| First Eagle Small Cap Opportunity Fund First Eagle Funds | 0.39 % | as of Apr 30, 2026 ↗ |
| Global X Genomics & Biotechnology ETF GLOBAL X FUNDS | 0.32 % | as of Feb 28, 2026 ↗ |
| Harbor AlphaEdge Small Cap Earners ETF Harbor ETF Trust | 0.10 % | as of Apr 30, 2026 ↗ |
| NVIT Multi-Manager Small Company Fund Nationwide Variable Insurance Trust | 0.08 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 137 | +7 | 22,405,493 | -7.0 % |
| 2026Q1 | 130 | -3 | 24,083,892 | -2.9 % |
| 2025Q4 | 133 | +5 | 24,790,716 | +5.6 % |
| 2025Q3 | 128 | -25 | 23,468,285 | -14.4 % |
| 2025Q2 | 153 | -24 | 27,431,166 | -38.6 % |
| 2025Q1 | 177 | -12 | 44,692,056 | -5.2 % |
| 2024Q4 | 189 | -2 | 47,123,064 | +23.3 % |
| 2024Q3 | 191 | -4 | 38,219,190 | +21.4 % |
| 2024Q2 | 195 | -20 | 31,494,776 | -14.2 % |
| 2024Q1 | 215 | -37 | 36,726,128 | -22.9 % |
| 2023Q4 | 252 | 47,663,209 |
Institutional managers
154 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| GTCR LLC | 20,150,005 | 57M $ | as of Mar 31, 2026 |
| BRAIDWELL LP | 10,240,164 | 29M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 9,345,268 | 26.4M $ | as of Mar 31, 2026 |
| 12 West Capital Management LP | 7,260,195 | 20.5M $ | as of Mar 31, 2026 |
| MACKENZIE FINANCIAL CORP | 6,306,425 | 17.8M $ | as of Mar 31, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | 4,264,689 | 12.1M $ | as of Mar 31, 2026 |
| Tejara Capital Ltd | 3,495,187 | 9.9M $ | as of Mar 31, 2026 |
| Monaco Asset Management SAM | 3,421,020 | 9.7M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 3,319,325 | 9.4M $ | as of Mar 31, 2026 |
| Point72 Asset Management, L.P. | 3,205,496 | 9.1M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 2,828,595 | 8M $ | as of Mar 31, 2026 |
| Philosophy Capital Management LLC | 2,637,117 | 7.5M $ | as of Mar 31, 2026 |
| First Eagle Investment Management, LLC | 2,524,336 | 7.1M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 2,428,717 | 6.9M $ | as of Mar 31, 2026 |
| MARSHALL WACE, LLP | 2,081,334 | 5.9M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 2,020,329 | 5.7M $ | as of Mar 31, 2026 |
| ROYCE & ASSOCIATES LP | 1,808,448 | 5.1M $ | as of Mar 31, 2026 |
| GENERAL AMERICAN INVESTORS CO INC | 1,716,193 | 4.9M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 1,649,490 | 4.7M $ | as of Mar 31, 2026 |
| JANE STREET GROUP, LLC | 1,636,145 | 4.6M $ | as of Mar 31, 2026 |
| TWO SIGMA INVESTMENTS, LP | 1,579,840 | 4.5M $ | as of Mar 31, 2026 |
| SYSTEMATIC FINANCIAL MANAGEMENT LP | 1,484,539 | 4.2M $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 1,484,319 | 4.2M $ | as of Mar 31, 2026 |
| DIMENSIONAL FUND ADVISORS LP | 1,418,597 | 4M $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 1,110,914 | 3.1M $ | as of Mar 31, 2026 |
Declared shareholders of Maravai LifeSciences Holdings Inc
There are 3 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Hudson View Holdings LLC and 6 others | 7.06 % | 10,337,680 | as of Mar 31, 2026 · SCHEDULE 13G |
| 12 West Capital Management LP and 1 other | 4.90 % | 7,260,195 | as of Mar 31, 2026 · SCHEDULE 13G |
| Millennium Management LLC and 2 others | 4.70 % | 6,900,258 | as of Jun 23, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Fund shareholders of Maravai LifeSciences Holdings Inc". https://titelia.com/en/stocks/maravai-lifesciences-holdings-inc-US56600D1072